ARTA
DARE icon

A.R.T. Advisors’s Dare Bioscience DARE Stock Holding History

A.R.T. Advisors’s Portfolio DARE Stock Details DARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-2,328
Closed -$27K – 1386
2018
Q3 		$27K Buy
+2,328
New +$31.3K ﹤0.01% 1339
2017
Q2 		– Sell
-806
Closed -$78K – 1474
2017
Q1 		$78K Buy
806
+312
+63% +$45K ﹤0.01% 1298
2016
Q4 		$41K Buy
+494
New +$47.1K ﹤0.01% 1223
2016
Q3 		– Sell
-115
Closed -$29K – 763
2016
Q2 		$29K Buy
+115
New +$36.8K ﹤0.01% 1290
2016
Q1 		– Sell
-163
Closed -$54K – 1415
2015
Q4 		$54K Buy
163
+67
+70% +$27.8K ﹤0.01% 1378
2015
Q3 		$42K Buy
+96
New +$48.3K ﹤0.01% 1301

Other funds holding DARE

PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
PP
Paloma Partners Greenwich, Connecticut $510M AUM 286.05% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

A.R.T. Advisors's DARE Position: Q4 2018 in Review

A.R.T. Advisors sold out of Dare Bioscience (DARE) in Q4 2018, closing a stake of 2,328 shares — an estimated $27K sold.

A.R.T. Advisors first reported a position in DARE in Q3 2015 and held it in 6 quarters. The position peaked at $78K in Q1 2017. 16 funds tracked by Wall St. Rank hold DARE as of Q4 2018.

  • A.R.T. Advisors reported no remaining Dare Bioscience position as of Q4 2018 after selling out during the quarter.
  • A.R.T. Advisors sold 2,328 Dare Bioscience shares in Q4 2018, an estimated $27K.
  • A.R.T. Advisors first reported a position in Dare Bioscience in Q3 2015 and held it in 6 quarters.
  • A.R.T. Advisors's Dare Bioscience position peaked at $78K in Q1 2017.
  • 16 funds tracked by Wall St. Rank held Dare Bioscience as of Q4 2018.

Based on A.R.T. Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.